Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 337 - 344 of 12016 results
New York Employers Must (Again) Provide Reproductive Health Notice of Rights in Employee Handbooks Following Second Circuit Ruling
January 21, 2025| Blog| Viewpoint
Mintz Toronto Is in for the Long Haul as It Nears Two Years Proving Naysayers Wrong
January 17, 2025| News
Out with a Bang: President Biden Ends Final Week in Office with Three AI Actions — AI: The Washington Report
January 17, 2025| Article| Viewpoint
Tax-Exempt Bonds Axed in Menu of Options Floated by Ways and Means
January 17, 2025| News
Health Care Enforcement Trends & 2025 Outlook
January 17, 2025| Blog| Viewpoint
ETA Travel Requirement for Visitors to The United Kingdom
January 16, 2025| Resources| Viewpoint
EnforceMintz — Health Care Enforcement Trends & 2025 Outlook
January 16, 2025| Blog| Viewpoint
2025 FERC, DOE Outlook: Surging Demand Growth to Drive Power-Sector Agenda
January 16, 2025| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|